Successful allogenic bone marrow transplant post reduced-intensity conditioning chemotherapy in an adult patient with severe phenotype Glanzmann thrombasthenia: A case report
Abstract:Background: In patients with severe Glanzmann thrombasthenia (GT), a genetic platelet surface receptor disorder of glycoprotein IIb/IIIa (integrin αIIbβ3) that results in prolonged and chronic bleeding, hematopoietic stem cell transplantation (HSCT) is the only curative treatment option. Unfortunately, approximately 30% of all patients undergoing HSCT die from this toxic procedure, owing to the associated risk of infection or chronic graft-versus-host disease, with adults at a higher risk.Case presentation: He… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.